Moderna
MRNA
NASDAQ
IPO2018
about MRNA
Moderna is a biotechnology company focused on developing vaccines and therapeutic agents using messenger RNA (mRNA) technology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $54.31 | $55.09 | $51.44 | $20.8B | 6.61M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.51 | n/a | n/a | -25.59% | -19.69% | 0% |